Navigation Links
Vertellus Specialties Completes Upgrades for API Niacin Manufacture
Date:5/2/2013

INDIANAPOLIS, May 2, 2013 /PRNewswire/ -- Vertellus Specialties Inc. announces that its facility in Antwerp, Belgium has completed capital and other upgrades for the manufacture of Niacin (nicotinic acid) for pharmaceutical use.

The plant has been producing Niacin USP and Niacinamide for nearly 30 years and has reliably supplied the ingredient for human food applications as well as agricultural needs. Vertellus completed projects over the last year to upgrade the facility to meet stringent guidelines necessary to be fully compliant with current Good Manufacturing Practice (cGMP) in manufacture of an Active Pharmaceutical Ingredient (API) and has been inspected and deemed acceptable by the US Federal Drug Administration.

"We are very excited to broaden our market capabilities to include pharmaceutical use for Niacin," says Bentley Park , President of Vertellus Agriculture & Nutrition Specialties LLC. "Among other applications, Niacin increasingly is used as a critical ingredient in drugs that help improve cardiovascular health by increasing good cholesterol levels. We can now provide another source and more options for pharmaceutical companies making those life-saving drugs."

Major changes at the plant include upgrades and validation of all critical equipment, manufacturing processes, analytical methodology and data collection systems.

To learn more about Vertellus' API Niacin manufacture capabilities call us at 1-800-777-3536 option 2.

About Vertellus: Vertellus is a specialty chemicals company focused on the manufacture of ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and a host of other market areas affected by trends favoring "green" technologies and chemistries. Vertellus is the #1 global producer of pyridine and picolines, specialty pyridine derivatives, DEET, castor oil derivatives and systems, and citrate polymer additives and systems, and a world leader in Vitamin B-3.  Vertellus benefits from a technically-advanced global manufacturing base and has approximately 800 employees.  Vertellus is headquartered in Indianapolis, Indiana.


'/>"/>
SOURCE Vertellus Specialties Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vertellus Specialties Selects HORN Essentials as Regional Distribution Partner in US West and Southwest for Personal and Consumer Care Products
2. Elsevier Launches ClinicalKey for Individual Clinicians, Providing Comprehensive Content for 41 Specialties
3. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
6. CryoLife Completes Acquisition of Hemosphere
7. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
8. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
9. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
10. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
11. Ablative Solutions Completes $5.3M Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% of its original funding goal. With ... to backers starting May of this year. Photo - ... ... ... Created by NAMU, a team of biomedical engineers out of South Korea ...
(Date:2/11/2016)... 11, 2016 Transformational M&A achieved through ...   --> Transformational M&A achieved through NPS and ... --> Transformational M&A achieved through NPS and Dyax ... Positioned for future growth with most robust pipeline in Shire ... for future growth with most robust pipeline in Shire ...
(Date:2/11/2016)... Feb. 11, 2016 Brain Cancer patients ... method at West Cancer Center . Optune™, ... to inhibit cancer cell replication causing death of cancer ... a decade to show a significant extension in overall ... patients. Currently, West Cancer Center is the only medical ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... The president released a ... Health System but would shift more of the cost burden to military beneficiaries. ... laid out in the defense budget as including limited quantifiable benefit fixes mixed with ...
(Date:2/11/2016)... ... February 11, 2016 , ... In a new paper ... surgeon , Dr. Rod J. Rohrich, and colleagues, examine and underscore the importance ... for rhinoplasty surgeons when addressing this vital area. , The upper lateral cartilage ...
(Date:2/11/2016)... ... 11, 2016 , ... PharmMD CEO Robert Yeager ... focus on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will ... in data breaches for the Part D Star Rating improvement and Medication Therapy ...
(Date:2/11/2016)... ... February 11, 2016 , ... Talix ... Family Practice , will be presenting at the 2016 HIMSS Annual Conference & ... , During his session, “ Coding for Care: Using Data Analytics for ...
(Date:2/11/2016)... ... 2016 , ... Be Well Medical Group (Be Well) is pleased ... at 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is ... the convenience of their homes, offices or at the practices’ local office. It is ...
Breaking Medicine News(10 mins):